Compounds > diethylstilbestrol

diethylstilbestrol and finasteride

diethylstilbestrol has been researched along with finasteride in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (42.86)18.2507
2000's2 (28.57)29.6817
2010's2 (28.57)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY1
Berman, C; Brooks, JR; Nguyen, H; Prahalada, S; Primka, RL; Rasmusson, GH; Slater, EE1
Heston, WD; Huryk, R; Perez, G; Russo, P; Warner, JA1
Cunha, GR; Hayashi, N; Kawamura, J; Sugimura, Y; Yamashita, A1
Hellerstedt, B1
Carroll, PR; Cowan, JE; DuChane, J; Elkin, EP; Kawakami, J; Latini, DM1
Borgert, CJ; Casella, G; Dietrich, DR; Golden, RJ; McCarty, LS; Sargent, EV1

Reviews

1 review(s) available for diethylstilbestrol and finasteride

ArticleYear
Hormonal therapy options for patients with a rising prostate-specific antigen level after primary treatment for prostate cancer.
    Urology, 2003, Dec-29, Volume: 62 Suppl 1

    Topics: Adenocarcinoma; Androgen Antagonists; Androgens; Anilides; Antineoplastic Agents, Hormonal; Chemotherapy, Adjuvant; Combined Modality Therapy; Diethylstilbestrol; Disease-Free Survival; Drug Administration Schedule; Enzyme Inhibitors; Finasteride; Gonadotropin-Releasing Hormone; Humans; Male; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplasms, Hormone-Dependent; Nitriles; Orchiectomy; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Salvage Therapy; Tosyl Compounds; Treatment Outcome

2003

Other Studies

6 other study(ies) available for diethylstilbestrol and finasteride

ArticleYear
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
    Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10

    Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding

2012
Effect of castration, DES, flutamide, and the 5 alpha-reductase inhibitor, MK-906, on the growth of the Dunning rat prostatic carcinoma, R-3327.
    The Prostate, 1991, Volume: 18, Issue:3

    Topics: 5-alpha Reductase Inhibitors; Androgens; Androstenes; Animals; Azasteroids; Diethylstilbestrol; Finasteride; Flutamide; Male; Orchiectomy; Prostatic Neoplasms; Rats; Rats, Inbred F344

1991
TRPM-2 gene expression in normal rat ventral prostate following castration and exposure to diethylstilbestrol, flutamide, MK-906 (finasteride), and coumarin.
    The Prostate, 1994, Volume: 24, Issue:5

    Topics: Animals; Apoptosis; Body Weight; Clusterin; Coumarins; Diethylstilbestrol; Finasteride; Flutamide; Gene Expression Regulation; Genetic Markers; Glycoproteins; Male; Molecular Chaperones; Orchiectomy; Organ Size; Prostate; Rats; Rats, Sprague-Dawley; RNA, Messenger; Testosterone

1994
Influence of diethylstilbestrol, Leuprolelin (a luteinizing hormone-releasing hormone analog), Finasteride (a 5 alpha-reductase inhibitor), and castration on the lobar subdivisions of the rat prostate.
    The Prostate, 1996, Volume: 29, Issue:1

    Topics: 5-alpha Reductase Inhibitors; Amino Acid Sequence; Animals; Diethylstilbestrol; Dihydrotestosterone; DNA; Enzyme Inhibitors; Finasteride; Gonadotropin-Releasing Hormone; Male; Molecular Sequence Data; Orchiectomy; Organ Size; Prostate; Proteins; Rats; Rats, Sprague-Dawley; Testosterone; Zinc

1996
Androgen-deprivation therapy as primary treatment for localized prostate cancer: data from Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE).
    Cancer, 2006, Apr-15, Volume: 106, Issue:8

    Topics: Adenocarcinoma; Aged; Aged, 80 and over; Androgen Antagonists; Antineoplastic Agents, Hormonal; Diethylstilbestrol; Enzyme Inhibitors; Finasteride; Gonadotropin-Releasing Hormone; Humans; Longitudinal Studies; Male; Middle Aged; Neoplasms, Hormone-Dependent; Orchiectomy; Prostatic Neoplasms; Survival Rate

2006
The human relevant potency threshold: reducing uncertainty by human calibration of cumulative risk assessments.
    Regulatory toxicology and pharmacology : RTP, 2012, Volume: 62, Issue:2

    Topics: Androgen Antagonists; Animals; Calibration; Diethylstilbestrol; Dose-Response Relationship, Drug; Endpoint Determination; Finasteride; Humans; Rats; Research Design; Risk Assessment; Species Specificity; Uncertainty

2012